Prevalence and prognosis of unclassifiable interstitial lung disease

Christopher J. Ryerson, Thomas H. Urbania, Luca Richeldi, Joshua J. Mooney, Joyce S. Lee, Kirk D. Jones, Brett M. Elicker, Laura L. Koth, Talmadge E. King, Jr, Paul J. Wolters, Harold R. Collard

Source: Eur Respir J 2013; 42: 750-757
Journal Issue: September
Disease area: Interstitial lung diseases

Congress or journal article abstractFull text journal articlePDF journal article, handout or slides

Rating: 0
You must login to grade this presentation.

Share or cite this content

Citations should be made in the following way:
Christopher J. Ryerson, Thomas H. Urbania, Luca Richeldi, Joshua J. Mooney, Joyce S. Lee, Kirk D. Jones, Brett M. Elicker, Laura L. Koth, Talmadge E. King, Jr, Paul J. Wolters, Harold R. Collard. Prevalence and prognosis of unclassifiable interstitial lung disease. Eur Respir J 2013; 42: 750-757

You must login to share this Presentation/Article on Twitter, Facebook, LinkedIn or by email.

Member's Comments

No comment yet.
You must Login to comment this presentation.


Related content which might interest you:
Clinical characteristics of patients with unclassifiable interstitial lung disease
Source: International Congress 2015 – New insights into IIPs
Year: 2015

Comorbidities in unclassifiable interstitial lung disease
Source: Virtual Congress 2020 – Addressing unresolved questions in rare diffuse parenchymal lung diseases: interdisciplinary research is the key
Year: 2020


Clusters of comorbidities in unclassifiable interstitial lung disease
Source: Virtual Congress 2021 – Interstitial lung disease around the world
Year: 2021


Progression of Rheumatoid-arthritis associated interstitial lung disease by radiological subtype
Source: International Congress 2018 – CTD-ILD and hypersensitivity pneumonitis:  mechanistic insights and prognostic markers
Year: 2018

Predictors of mortality and risk prediction among patients with scleroderma related interstitial lung disease
Source: International Congress 2015 – IPF: clinical aspects II
Year: 2015



Variation in mortality from interstitial lung disease by diagnosis
Source: International Congress 2015 – IIPs: orphan
Year: 2015


Interstitial lung disease: improving classification and prognosis
Source: Virtual Congress 2021 – Clinical year in review
Year: 2021


The epidemiology of idiopathic pulmonary fibrosis and interstitial lung diseases at risk of a progressive-fibrosing phenotype
Source: Eur Respir Rev, 27 (150) 180077; 10.1183/16000617.0077-2018
Year: 2018



Emphysema frequency in the cases who have interstitial lung disease diagnosis
Source: Annual Congress 2008 - Clinical aspects of interstitial lung disease
Year: 2008

Treatment and prognosis of lung cancer associated with interstitial pneumonia
Source: Annual Congress 2010 - Thoracic malignancies: interesting case studies and series
Year: 2010


The analysis of prognostic factors in patients with interstitial lung diseases
Source: International Congress 2015 – New insights into IIPs
Year: 2015


Incidence and predictive factors of lung cancer in patients with idiopathic pulmonary fibrosis
Source: ERJ Open Res, 4 (1) 00111-2016; 10.1183/23120541.00111-2016
Year: 2018



Prevalence of progressive fibrosing interstitial lung disease
Source: International Congress 2018 – Pitfalls in the diagnosis and management of rare diffuse parenchymal lung diseases (DPLDs)
Year: 2018


Prognostic factors of interstitial lung disease associated with primary Sjögren's syndrome
Source: Annual Congress 2013 –Diffuse parenchymal lung disease I
Year: 2013


Using the ILD-GAP model to predict mortality in chronic interstitial lung disease
Source: International Congress 2015 – IIPs: orphan
Year: 2015


Clinical characteristics of anti-Jo-1-positive interstitial lung disease
Source: International Congress 2019 – From biomarkers to treatment of immune-mediated interstitial lung disease: what’s new?
Year: 2019


The management of children with interstitial lung disease
Source: International Congress 2018 – Difficult paediatric lung disease
Year: 2018


Chronic obstructive pulmonary disease and interstitial lung disease could predict poor long-term survivals after pulmonary resection for lung cancer
Source: Eur Respir J 2002; 20: Suppl. 38, 38s
Year: 2002

The clinical value of surgical lung biopsy in 166 patients with suspected interstitial lung disease
Source: International Congress 2015 – New insights into IIPs
Year: 2015